Chemotherapy Transition to Outpatient Setting Maintains Care at Less Cost

Share this content:
Inpatient space availability can pose a challenge in traditional chemotherapy settings.
Inpatient space availability can pose a challenge in traditional chemotherapy settings.
The following article features coverage from the National Association of Clinical Nurse Specialists (NACNS) 2018 Annual Conference in Austin, Texas. Click here to read more of Oncology Nurse Advisor's conference coverage. 

Transitioning chemotherapy regimens traditionally administered in the inpatient setting effectively reduces costs to patients and the organization while maintaining patient satisfaction with the care, according to a presentation at the National Association of Clinical Nurse Specialists (NACNS) 2018 Annual Conference.

Many chemotherapy regimens are administered exclusively in the inpatient setting; however, inpatient bed availability was presenting a challenge at our facility that led to a re-evaluation of the idea of requiring regimens be administered in 1 care setting, reported study authors from Froedtert & the Medical College of Wisconsin.

An interprofessional group at the facility sought to create a new cost-effective, patient-centered standard of care, by transitioning regimens traditionally administered in the inpatient unit to the outpatient setting. For this study, the group reviewed existing orders, materials, and processes to create modifications that would address medication-specific issues, patient-specific requirements, and processes of care, enabling a successful transition.

Working from a program overview, the group modified each treatment plan and standardized its teaching plan for use in the ambulatory setting. Supportive documents and a follow-up plan were created to ensure the model was working in the new setting.

Our team has successfully transitioned several regimens to the ambulatory setting, which has proven to be a superior value: patients receive equivalent treatment with less time in the healthcare setting, reporting continued satisfaction with their care experience, and costs are reduced for both patients and the organization.

Reference

Cotter J, Portz D. "Where we're going we don't need roads": defining the future of oncology infusion care. Oral presentation at: NACNS 2018 Annual Conference; February 28-March 3, 2018; Austin, TX.

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs